  Therapeutic protons acting on O18-substituted thymidine increase cytotoxicity
in radio-resistant human cancer cells. We consider here the physics behind the
irradiation during proton beam therapy and diagnosis using O18-enriched thymine
in DNA, with attention to the effect of the presence of thymine-18 on cancer
cell death.
